Reducing the risk of pertussis in newborn infants

Journal of Preventive Medicine and Hygiene

Volumn 50, Issue 4, 2009, Pages 206-216

  Blangiardi, F ^a   Ferrera, Giuseppe ^b  

^a Prevention Department   (Italy)

^b Ragusa LHA   (Italy)

Author keywords

Booster vaccination; Bordetella pertussis; Cocoon; Italy

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; WART VIRUS VACCINE;

ADOLESCENT; ANTIBODY TITER; ARTHRALGIA; BACTERIAL INFECTION; BOOSTER VACCINATION; BORDETELLA PERTUSSIS; CHILD; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; DIPHTHERIA; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEVER; GASTROINTESTINAL TOXICITY; HEADACHE; HEALTH PROGRAM; HUMAN; IMMUNE RESPONSE; INFANT; ITALY; MYALGIA; NEWBORN; NEWBORN CARE; NEWBORN DISEASE; PERTUSSIS; PNEUMOCOCCAL INFECTION; RASH; REPEATED DRUG DOSE; RESPIRATORY TRACT INFECTION; REVACCINATION; REVIEW; SEROCONVERSION; SINGLE DRUG DOSE; TETANUS; TREATMENT OUTCOME; URTICARIA; VACCINATION; VIRUS INFECTION; ADULT; FEMALE; HEALTH EDUCATION; IMMUNIZATION; IMMUNOLOGY; PREGNANCY; PRENATAL CARE; PRESCHOOL CHILD; TRANSMISSION; WHOOPING COUGH;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HEALTH EDUCATION; HUMANS; IMMUNIZATION, SECONDARY; INFANT; INFANT, NEWBORN; ITALY; PERTUSSIS VACCINE; PREGNANCY; PRENATAL CARE; WHOOPING COUGH;

EID: 77953267795     PISSN: 11212233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Tan T, Trindale E, Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis J 2005;24:S10-S18.
2. de Melker H, Versteegh F, Schellekens J, Teunis PF, Kretzschmar M. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect 2006;53:106-113
3. Galanis E, King A, Varughese P, Halperin SA; IMPACT investigators. Changing epidemiology and emerging risk groups for pertussis. CMAJ 2006;174:451-452
4. Forsyth KD, Wirsing von Konig CH, Tan T, Caro J, Plotkin S. Prevention of pertussis: reccomendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 2007;25:2634-2642
5. Centers for Disease Control and Prevention. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2006;55 (December 15, 2006).
6. Wood N, Quinn HE, McIntyre P, Elliott E. Pertussis in infants: Preventing deaths and hospitalisations in the very young. J Paediatr Child Health 2008;44:161-165
7. th ed. Philadelphia, PA: Saunders Co. 2004, pp. 471-528.
8. The Italian Vaccine Coverage Survey Working Group. Childhood vaccination coverage in Italy: results of a seven-region survey. Bull World Health Org 1994;72:885-895
9. Binkin NJ, Salmaso S, Tozzi AE, Scuderi G, Greco D, Greco D. Epidemiology of pertussis in a developed country with low vaccination cover-age: the Italian experience. Pediatr Infect Dis J 1992;11:653-661
10. Salmaso S, Rota MC, Ciofi degli Atti ML, Tozzi AE, Kreidl P, the ICONA Study Group. Infant immunization coverage in Italy: estimates by simultaneous EPI cluster surveys of regions. Bull World Health Org 1996;77:843-851
11. ICONA 2008: Indagine di Copertura vaccinale Nazionale nei bambini e negli adolescenti. Reports ISTISAN: 09/29. www.iss.it
12. Rota MC, D'Ancona F, Massari M, Mandolini D, Giammanco A, Carbonari P, et al. How increased pertussis vaccination coverage is changing the epidemiology of pertussis in Italy. Vaccine 2005;23:5299-5305
13. Gabutti G, Bergamini M, Bonanni P, Guido M, Fenoglio D, Giammanco A, et al. Assessment of humoral and cell mediated immunity against Bordetella pertussis in adolescent, adult and senior subjects in Italy. Epidemiol Infect 2008;136:1576-1584
14. Wirsing von König CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infectiuous Diseases 2002;2:744-750
15. Cherry JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 2005;115:1422-1427
16. Wood N, McIntyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Paediatric Respiratory Reviews 2008;9:201-212
17. http://www.ministerosalute.it/programmazione/sdo/sdo.jsp
18. Cuccia M. La necessità di continuità nella protezione vaccinale contro la pertosse: il contagio dall'adolescente/adulto al neonate. J Prev Med Hyg 2004;45(Suppl. 1):8-10.
19. Celentano L, Massari M, Paramatti D, Salmaso S, Tozzi AE; EUVAC-NET Group. Resurgence of pertussis in Europe. Pediatr Infect Dis J 2005;24:761-765
20. Horcajada Herrera I, Hernández Febles M, González Jorge R, Colino Gil E, Bordes Benítez A, Pena López MJ. Epidemiology and clinical study of Bordetella pertussis in Gran Canaria Island, Spain, in the period 2003-2007. An Pediatr (Barc) 2008;69:200-204
21. Bonmarin I, Bouraoui L, Guiso N, Levy-Bruhl D. Pertussis: data collection and vaccinal strategy. Med Malad Infect 2009;39:271-277
22. Centers for Disease Control and Prevention. Pertussis: United States, 2001-2003. MMWR Morb Mortal Wkly Rep 2005;54:1283-1286
23. Hewlett EL. Pertussis: current concepts of pathogenesis and prevention. Pediatr Infect Dis J 1997;16:S90-S96.
24. Bamberger ES, Srugo I. What is new in pertussis? Eur J Pediatr 2008;167:133-139
25. Esposito S, Agliardi T, Giammanco A, Faldella G, Cascio A, Bosis S, et al. Long-term pertussis-specific immunity after primari vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection. Infect immune 2001;69:4516-4520
26. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005;24:S58-61.
27. Poolman JT, Hallander HO. Acellular pertussis vaccines and the role of pertactin and fimbriae. Expert Rev Vaccines 2007;6:47-56.
28. Jefferson T, Rudin M, Di Pierantonj C. Systematic review of the effects of pertussis vaccines in children. Vaccine 2003;21:2003-2014
29. Framton JE, Keating GM. Reduced-antigen combined diphtheria, tetanus and acellular pertussis vaccine (Boostrix). A review of its use as single-dose booster immunization. Biodrugs 2006;20:371-389
30. Di Pasquale A. dTpa-IPV: un nuovo vaccino combinato GlaxoSmithKline per nuove esigenze e prospettive nella Sanità Pubblica. J Prev Med Hygiene 2004;45(Suppl.1):11-13
31. Pichichero ME, Casey JR. Acellular pertussis vaccines for adolescents. Pediatr Infect Dis J 2005;24:S117-S26.
32. Knuf M, Zepp F, Meyer C, Grzegowski E, Wolter J, Riffelmann M, et al. Immunogenicity of a single dose of reduced antigen acellular pertussis vaccine in non-vaccinated adolescent population. Vaccine 2006;24:2043-2048
33. th ESPID, Brussels, 9-13 June 2009.
34. McIntyre PB, Burgess MA, Egan A, Schuerman L, Hoet B. Booster vaccination of adults with reduced-antigen content diphtheria, tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination. Vaccine 2009;27:1062-1066
35. Theeten H, Rümke H, Hoppener FJ, Vilatimó R, Narejos S, Van Damme P, et al. Primary vaccination of adults with reduced antigen-content diphtheria-tetanus-acellular pertussis or dTpa-inactivated poliovirus vaccines compared to diphtheria-tetanus-toxoid vaccines. Curr Med Res Opin 2007;23:2729-2739
36. Conferenza permanente per i rapporti tra lo Stato, Regioni e le Province Autonome di Trento e Bolzano. Determinazione 3 marzo 2005. Accordo ai sensi dell'art 4 del decreto legislativo 28 agosto 1997, n. 281, tra il Ministro della salute e i Presidenti delle regioni e delle province autonome, concemente il Nuovo Piano Nazionale Vaccini 2005-2007. GU n. 86 del 14-04-2005 - Suppl ordinario n.63.
37. Recommendation: Conseil Supérieur d'Hygiène Belgique, February 2008.
38. Calendrier Vaccinel 2008 - Bulletin Epidemiologique Hebdomadaire - n. 16-17, April 2008.
39. Robert-Koch-Institut and STIKO- Epidemiologisches Bullettin n. 30, 28 July 2006.
40. th ESPID, Brussels, 9-13 June 2009.
41. Campins-Martì M, Cheng HK, Forsyth K, Guiso N, Halperin S, Huang LM, et al. Recommendations are needed for adolescent and adult pertussis immunization: rationale and strategies for consideration. International Consensus Group on Pertussis Immunisation. Vaccine 2001;20:641-646
42. Sin MA, Zenke R, Rönckendorf R. et al. Pertussis outbreak in primary and secondary schools in Ludwigslust, Germany demonstrating the role of waning immunity. Ped Infect Dis J 2009;28:242-244
43. Coudeville L, Van Rie A, Andre P. Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies. Epidemiol Infect 2008;136:604-620
44. MMWR (Morbidity and Mortality Weekly Report) May 30, 2008 / Vol. 57 / No. RR.
45. Scuffham PA, McIntyre PB. Pertussis vaccination strategies for neonates - an exploratory cost-effectiveness analysis. Vaccine 2004;22:2953-2964
46. th ESPID, Brussels, 9-13 June 2009.
47. Presidential Decree No. 464 of 7 November 2001, Official Gazette No. 7 of 09 January 2002.
48. Pedalino B, Cotter B, Ciofi degli Atti M, Mandolini D, Parroccini S, Salmaso S. Epidemiology of tetanus in Italy years 1971-2000. Euro Surveill 2002;7:103-110
49. Edmunds WJ, Pebody RG, Aggerback H, Baron S, Berbers G, Conyn-van Spaendonck MA, et al. The sero-epidemiology of diphtheria in Western Europe. Epidemiol Infect 2000;125:113-125